Grey Wolf Health Corp.

As of June 30, 2026, Grey Wolf Health Corp. carries a market capitalization of 60.62M, placing it among publicly traded companies globally. Its enterprise value stands at 76.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Grey Wolf Health Corp. has 34.64M shares outstanding.

As of June 30, 2026, Grey Wolf Health Corp. trades at a trailing price-to-earnings ratio of 39.35. The price-to-sales ratio is 1.60, and the price-to-book ratio stands at 1.91.

As of June 30, 2026, Grey Wolf Health Corp. trades at an EV/EBITDA multiple of 11.36 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 19.21 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Grey Wolf Health Corp. trades at an EV/FCF ratio of 13.70, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 76.15M versus a market cap of 60.62M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Grey Wolf Health Corp. maintains a current ratio of 2.74, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 76.98, indicating elevated leverage, while an interest coverage ratio of 3.89 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Grey Wolf Health Corp. posted a return on equity (ROE) of 4.97, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.64 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.35, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 4.73, useful for judging operating efficiency across full business cycles. Inventory turnover of 3.10 indicates how many times Grey Wolf Health Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Grey Wolf Health Corp. recorded 787,065.00 in income tax expense. That works out to an effective tax rate of 34.02, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.31M, leaving 1.53M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Grey Wolf Health Corp.'s stock has gained approximately 23.13% over the past 52 weeks. The 50-day moving average sits at 1.69, while the 200-day moving average is 1.52.

Over the twelve months ended June 30, 2026, Grey Wolf Health Corp. generated 37.65M in revenue and converted that into 1.53M in net income, yielding earnings per share of 0.04. EBITDA reached 6.70M, while operating income came in at 3.96M.

As of June 30, 2026, Grey Wolf Health Corp. holds 8.90M in cash and equivalents against 24.44M in total debt, resulting in a net debt position of 15.19M. Total book value stands at 31.74M, with working capital of 11.24M providing operational flexibility.

Grey Wolf Health Corp. produced 5.04M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -619,175.00 in capital expenditures, free cash flow totaled 4.42M - equivalent to 0.13 per share.

Over the twelve months ended June 30, 2026, Grey Wolf Health Corp. posted a gross margin of 53.61, reflecting its pricing power and cost economics. The operating margin of 10.53 and net profit margin of 4.05 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 7.23, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.73, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Grey Wolf Health Corp. shareholders.

Grey Wolf Health Corp.'s most recent stock split took place on November 23, 2022 with a 50:3 split ratio.

As of June 30, 2026, Grey Wolf Health Corp. has an Altman Z-Score of 3.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.